Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 19Ovarian Neoplasms 11Neoplasms 7Liposarcoma 7Leiomyosarcoma 7Neoplasm Metastasis 4Sarcoma, Ewing 3Breast Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Neoplasms by Site 2Liposarcoma, Myxoid 2Histiocytoma, Malignant Fibrous 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Soft Tissue Neoplasms 1Skin Diseases 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Recurrent High Grade Meningioma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Ovarian Diseases 1

Interventions

Filgrastim 18Cyclophosphamide 13Etoposide 12Peripheral Blood Stem Cell Transplantation 11Ifosfamide 11Vincristine 9Carboplatin 9Radiotherapy 8Doxorubicin 8Melphalan 7Topotecan 6Temozolomide 5Granulocyte Colony-Stimulating Factor 5Busulfan 5Thiotepa 4Irinotecan 4Docetaxel 4trioctyl phosphine oxide 3cixutumumab 3Imatinib Mesylate 3Amifostine 3tanespimycin 2pegfilgrastim 2ixabepilone 2etoposide phosphate 2Oxaliplatin 2Neoadjuvant Therapy 2Microarray Analysis 2Mesna 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors, Primitive, Peripheral × Trabectedin × Clear all
NCT00070109 2018-09-14

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Children's Oncology Group

Phase 2 Completed
50 enrolled 18 charts
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡